Go Healthy Initiates Additional Clinical Tests on Cholesterade

May 8, 2008 8:54 AM EDT

HOUSTON, May 8 /PRNewswire-FirstCall/ -- Go Healthy (Pink Sheets: GOHE) announces the initiation of further clinical trials with Cholesterade (R) in three medical settings with an expected patient clinical group of 200 patients in 6 centers around the country. Dr. William Bryan of the Sports Medicine Institute at The Methodist Hospital in the Texas Medical Center will coordinate one clinical trial. Dr. Bryan was formerly the Team Physician for the Houston Astros and the former Medical Director of Major League Baseball.

Dr. David Braunreiter of Memorial Hermann Hospital, the Team Physician for the Houston Dynamo and the NFL's Houston Texans will coordinate a center in Southwest Houston. Dr. Jason Pirozzolo of the Sports Medicine Institute at the Florida Hospital in Orlando will coordinate a third center, pending IRB approval. Pirozzolo recently completed Sports Medicine fellowships at the Ohio State University and Duke University.

Future centers will be coordinated by CO-PIs, Dr. Hal Goforth, widely acclaimed researcher on muscle glycogen metabolism from Point Loma Nazarene University and the Naval Research Center, and Dr. Fran Pirozzolo, Chairman of the Medical and Scientific Advisory Board of Go Healthy. Dr. Fran Pirozzolo was formerly the Chief of the Neuropsychology Service in the Department of Neurology at the Baylor College of Medicine. He was a Member of the National Academy of Sciences Committee on Techniques to Enhance Human Performance and has served on a number of NIH and NIMH advisory committees.

The study will be a double-blind crossover study of the efficacy of Cholesterade(R) in lowering cholesterol (total cholesterol and LDL) and triglycerides while increasing HDL and HDLC/LDLC ratio. The study will also employ a modified Experience Sampling Technique to measure the vitality of subjects throughout the day.

Charlie Caudle, CEO of Go Healthy, states that "We are very excited to be moving forward on studies that will expand on Dr. Cade's work and which we believe will conclusively demonstrate that Cholesterade(R) will bring a dramatic, meaningful contribution to the improvement of health in the cholesterol and other areas, including obesity and diabetes. This delicious drink will now allow the medical community to provide a compliance vehicle to meet NIH guidelines for 10-25 grams of dietary soluble fiber during a 12 week period of Therapeutic Lifestyle Changes prior to consideration of statin intervention. Subsequent studies we are planning will delve into those other areas and demonstrate the vital importance of dietary soluble fiber in general wellness."

Forward-Looking Statements Disclosure

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risks, and uncertainties, and by reference to the underlying assumptions.

     Contact:
     Charlie Caudle
     CEO - Go Healthy, Inc.
     (888) 282-7256

     Brokers and Analysts call
     Aero Financial, Inc
     972-265-7590

SOURCE Go Healthy, Inc.

Related Categories

Press Releases

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?